TGF-beta-dependent Suppressive Function of Tregs Requires Wild-type Levels of CD18 in a Mouse Model of Psoriasis

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2008 Jun 4

PMID 18521187

Citations 27

Authors

Honglin Wang

Thorsten Peters

Anca Sindrilaru

Daniel Kess

Tsvetelina Oreshkova

Xue-Zhong Yu

Anne Maria Seier

Heike Schreiber

Meinhard Wlaschek

Robert Blakytny

Jan Rohrbein

Guido Schulz

Johannes M Weiss

Karin Scharffetter-Kochanek

Affiliations

Soon will be listed here.

Abstract

Dysfunctional Tregs have been identified in individuals with psoriasis. However, their role in the pathogenesis of the disease remains unclear. Here we explored the effect of diminished CD18 (beta2 integrin) expression on the function of CD4+CD25+CD127(-) Tregs using the Cd18 hypomorphic (Cd18hypo) PL/J mouse model of psoriasis that closely resembles the human disease. We found that reduced CD18 expression impaired cell-cell contact between Tregs and DCs. This led to dysfunctional Tregs, which both failed to suppress the pathogenic T cells and promoted the onset and severity of the disease. This failure was TGF-beta-dependent, as Tregs derived from Cd18hypo PL/J mice had diminished TGF-beta1 expression. Adoptive transfer of Tregs expressing wild-type levels of CD18 into affected Cd18hypo PL/J mice resulted in a substantial improvement of the psoriasiform skin disease, which did not occur upon coinjection of the cells with TGF-beta-specific neutralizing antibody. Our data indicate a primary dysfunction of Cd18hypo Tregs, allowing subsequent hyperproliferation of pathogenic T cells in the Cd18hypo PL/J mouse model of psoriasis. This study may provide a step forward in our understanding of the unique role of CD18 expression levels in avoiding autoimmunity.

Citing Articles

Integrins in Health and Disease-Suitable Targets for Treatment?.

Klaus T, Hieber C, Bros M, Grabbe S Cells. 2024; 13(3.

PMID: 38334604 PMC: 10854705. DOI: 10.3390/cells13030212.

The Role of LFA-1 for the Differentiation and Function of Regulatory T Cells-Lessons Learned from Different Transgenic Mouse Models.

Klaus T, Wilson A, Fichter M, Bros M, Bopp T, Grabbe S Int J Mol Sci. 2023; 24(7).

PMID: 37047302 PMC: 10094578. DOI: 10.3390/ijms24076331.

Impaired Treg-DC interactions contribute to autoimmunity in leukocyte adhesion deficiency type 1.

Klaus T, Wilson A, Vicari E, Hadaschik E, Klein M, Helbich S JCI Insight. 2022; 7(24).

PMID: 36346673 PMC: 9869970. DOI: 10.1172/jci.insight.162580.

T-Cell Adhesion in Healthy and Inflamed Skin.

Moreau J, Gouirand V, Rosenblum M JID Innov. 2022; 1(2):100014.

PMID: 35024681 PMC: 8669513. DOI: 10.1016/j.xjidi.2021.100014.

The Role of Helper T Cells in Psoriasis.

Hu P, Wang M, Gao H, Zheng A, Li J, Mu D Front Immunol. 2022; 12:788940.

PMID: 34975883 PMC: 8714744. DOI: 10.3389/fimmu.2021.788940.

References

Conrad C, Boyman O, Tonel G, Tun-Kyi A, Laggner U, De Fougerolles A . Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nat Med. 2007; 13(7):836-42. DOI: 10.1038/nm1605. View

Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S . Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature. 2003; 426(6965):454-60. DOI: 10.1038/nature02119. View

Judkowski V, Pinilla C, Schroder K, Tucker L, Sarvetnick N, Wilson D . Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J Immunol. 2001; 166(2):908-17. DOI: 10.4049/jimmunol.166.2.908. View

Cozzo C, Larkin 3rd J, Caton A . Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J Immunol. 2003; 171(11):5678-82. DOI: 10.4049/jimmunol.171.11.5678. View

Kulkarni A, Huh C, Becker D, Geiser A, Lyght M, Flanders K . Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A. 1993; 90(2):770-4. PMC: 45747. DOI: 10.1073/pnas.90.2.770. View

Sugiyama H, Gyulai R, Toichi E, Garaczi E, Shimada S, Stevens S . Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol. 2004; 174(1):164-73. PMC: 2903964. DOI: 10.4049/jimmunol.174.1.164. View

Takahashi T, KUNIYASU Y, Toda M, Sakaguchi N, Itoh M, Iwata M . Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol. 1999; 10(12):1969-80. DOI: 10.1093/intimm/10.12.1969. View

Tang Q, Henriksen K, Boden E, Tooley A, Ye J, Subudhi S . Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol. 2003; 171(7):3348-52. DOI: 10.4049/jimmunol.171.7.3348. View

Gottlieb S, Gilleaudeau P, Johnson R, Estes L, Woodworth T, Gottlieb A . Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med. 1995; 1(5):442-7. DOI: 10.1038/nm0595-442. View

10.

Gaylor M, Duvic M . Generalized pustular psoriasis following withdrawal of efalizumab. J Drugs Dermatol. 2004; 3(1):77-9. View

11.

Tomfohrde J, Silverman A, BARNES R, Fernandez-Vina M, Young M, Lory D . Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science. 1994; 264(5162):1141-5. DOI: 10.1126/science.8178173. View

12.

Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig M, von Boehmer H . Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 2005; 6(12):1219-27. DOI: 10.1038/ni1265. View

13.

van Seventer G, Shimizu Y, Horgan K, Shaw S . The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol. 1990; 144(12):4579-86. View

14.

Shier P, Otulakowski G, Ngo K, Panakos J, Chourmouzis E, Christjansen L . Impaired immune responses toward alloantigens and tumor cells but normal thymic selection in mice deficient in the beta2 integrin leukocyte function-associated antigen-1. J Immunol. 1996; 157(12):5375-86. View

15.

Anderson D, Miller L, Schmalstieg F, Rothlein R, Springer T . Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies. J Immunol. 1986; 137(1):15-27. View

16.

Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A . Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med. 2006; 203(7):1693-700. PMC: 2118333. DOI: 10.1084/jem.20060468. View

17.

Gencik M, Meller S, Borgmann S, Sitter T, Menezes Saecker A, Fricke H . The association of CD18 alleles with anti-myeloperoxidase subtypes of ANCA-associated systemic vasculitides. Clin Immunol. 1999; 94(1):9-12. DOI: 10.1006/clim.1999.4811. View

18.

Putheti P, Pettersson A, Soderstrom M, Link H, Huang Y . Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. J Clin Immunol. 2004; 24(2):155-61. DOI: 10.1023/B:JOCI.0000019780.93817.82. View

19.

Shull M, Ormsby I, Kier A, Pawlowski S, Diebold R, Yin M . Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992; 359(6397):693-9. PMC: 3889166. DOI: 10.1038/359693a0. View

20.

Hartigan-OConnor D, Poon C, Sinclair E, McCune J . Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods. 2006; 319(1-2):41-52. DOI: 10.1016/j.jim.2006.10.008. View